OSGIN1 and pancreatitis: The FXR agonist GW4064 exhibited excellent therapeutic effects on pancreatitis; it could directly activate pancreatic acinar FXR to restore efficient autophagy mediated by enhanced Osgin1 expression, thus mitigate the severity of pancreatitis.